NCT02366611View on ClinicalTrials.gov

Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Cancer of Head and Neck
Interventions
DEVICE

Transcranial Direct Current Stimulation (tDCS)

tDCS is a non-invasive brain neuromodulatory method that involves sending a weak electrical current to the brain. 2mA of tDCS will be applied for 20 minutes at each session and participants will undergo a total of 20 sessions over a 7-week period.

Trial Locations (1)

48106

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT02366611 - Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer | Biotech Hunter | Biotech Hunter